Bone marrow necrosis in acute leukemia

Acta Haematologica
R M NavariR S Hillman

Abstract

2 patients with premortem marrow necrosis in acute leukemia are discussed. A review of the course of each patient plus those in the literature suggests that premortem marrow necrosis may not be a poor prognostic sign in acute lymphoblastic leukemia but generally precedes a prolonged and fatal pancytopenia in acute myelogenous leukemia. The technetium-99m rhenium sulfur colloid marrow scan was found to be of value in assessing the extent and degree of necrosis of the marrow as well as in documenting and predicting marrow recovery following chemotherapy.

Citations

Sep 5, 2002·American Journal of Hematology·Semra PaydasFiliz A Bolat
Jul 1, 1995·American Journal of Hematology·P M ParikhS Advani
Nov 1, 1994·American Journal of Hematology·L RanaghanG M Markey
Aug 23, 2000·Leukemia & Lymphoma·D L ForrestA Foyle
May 29, 2015·American Journal of Hematology·Talha BadarFarhad Ravandi
Dec 1, 1987·Scottish Medical Journal·H W Habboush, I M Hann
May 1, 1997·Annals of Saudi Medicine·L A Al-Gwaiz
Feb 6, 2021·Clinical Lymphoma, Myeloma & Leukemia·Ruge ChenLan Deng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.